Posttraumatic growth in head and neck cancer survivors: is it possible and what are the correlates? by Sharp L et al.
 
 
 
 
 
Newcastle University ePrints | eprint.ncl.ac.uk 
Sharp L, Redfearn D, Timmons A, Balfe M, Patterson JM. Post-traumatic growth 
in head and neck cancer survivors: is it possible and what are the correlates? 
Psycho-Oncology (2018)
DOI link 
https://doi.org/10.1002/pon.4682  
ePrints link 
http://eprint.ncl.ac.uk/246418  
Date deposited 
13/03/2018 
Embargo release date 
23/02/2019  
Copyright 
This is the peer reviewed version of the following article, which has been published in final 
form at https://doi.org/10.1002/pon.4682. This article may be used for non-commercial 
purposes in accordance with Wiley Terms and Conditions for Self-Archiving. 
 
 This article has been accepted for publication and undergone full peer review but has not 
been through the copyediting, typesetting, pagination and proofreading process which may 
lead to differences between this version and the Version of Record. Please cite this article as 
doi: 10.1002/pon.4682 
 
This article is protected by copyright. All rights reserved. 
Post-traumatic growth in head and neck cancer survivors: is it possible and what are the 
correlates?  
Linda Sharp1+, Devon Redfearn1+, Aileen Timmons2, Myles Balfe3, Joanne Patterson1 
1 Institute of Health & Society, Newcastle University, Newcastle-upon-Tyne, England.  
2 National Cancer Registry Ireland, Cork, Ireland.  
3 Department of Epidemiology & Public Health, University College Cork, Cork, Ireland.  
+ joint first authors 
Corresponding author: Linda Sharp, Institute of Health & Society, Newcastle University, Sir James 
Spence Institute, Royal Victoria Infirmary, Newcastle-upon-Tyne, England.  Tel +44 (0)191 208 6275; 
email: linda.sharp@ncl.ac.uk 
Running title: PTG after head and neck cancer 
Keywords: head and neck cancer, oral cancer, post-traumatic growth, quality-of-life, survivorship, 
cancer, oncology 
  
  
This article is protected by copyright. All rights reserved. 
ABSTRACT 
Objectives: Posttraumatic growth (PTG) is a possible positive consequence of a traumatic event, 
such as cancer.  Head and neck cancer (HNC) may be particularly traumatic, given its adverse effects 
on functional, psychological and social wellbeing.  We investigated: extent of PTG; factors associated 
with PTG; and associations between PTG and health-related quality-of-life (HRQoL) in HNC survivors.   
Methods: HNC survivors (ICD10 C00-C14, C32), identified from the population-based National 
Cancer Registry Ireland, completed a postal survey. PTG was assessed using the Posttraumatic 
Growth Inventory (PTG-I) and HRQoL with FACT-G and FACT-HN.  Associations between socio-
economic characteristics, social support, and clinical variables and PTG were examined using 
multivariable linear regression. Total HRQoL scores were compared in those with none-low PTG vs 
moderate-high PTG.  
Results: 583 survivors participated (response rate=59%). The mean PTG score was 55.74 (95%CI 
53.15-58.33); 60% had moderate-high PTG.  Survivors scored highest in the PTG-I domain 
appreciation of life. In multivariable analysis, being female, being younger, having more social 
support and having cancer-related financial stress were significantly associated with more PTG. 
HRQoL was significantly higher in those with moderate-high than no-little PTG (p<0.01)  
Conclusion: A notable proportion of HNC survivors report PTG but growth is, on average, lower than 
reported for other cancers.  Nonetheless, higher PTG appears related to better HRQoL. Further 
research would be valuable to understand the pathways by which HNC may lead to PTG and inform 
development of strategies to support and encourage PTG in this survivor population.  
  
  
This article is protected by copyright. All rights reserved. 
BACKGROUND 
A cancer diagnosis is a stressful event that may have significant long-term psychological, social and 
functional adverse effects.  This may be argued to be especially true of head and neck cancer (HNC). 
Treatment is frequently multi-model and often aggressive and, like survivors of many cancers, HNC 
survivors may experience various cancer-related symptoms, including fatigue and pain, which can 
result in quality-of-life decrements [1].  However, HNC and its treatment can also lead to visible 
disfigurement and have detrimental effects on many functions and activities of daily living; survivors 
often have problems with speech or voice, breathing, eating or swallowing and experience 
mucositis, xerostomia and trismus, all of which can impact adversely on psychological and social 
wellbeing [2-5].   
Recently interest has grown in the potential for cancer survivors to experience positive 
consequences of their illness. One such positive consequence is posttraumatic growth (PTG). PTG 
refers to positive changes that result from a struggle after a traumatic event [6]. It may occur in the 
months and years following the event and manifest in various ways including increased appreciation 
for life, more meaningful interpersonal relationships, and richer existential and spiritual life [6]. 
However, traumatic events are insufficient in themselves to cause PTG; instead an individual must 
reflect on their experiences and seek to find meaning in them [7] i.e. growth arises from adaptation 
to the trauma and rebuilding one’s sense of the world [6]. 
Accumulating research indicates PTG may occur among cancer survivors [7,8]  In HNC, one 
qualitative study suggested most survivors may experience positive changes, including changed 
attitudes towards life, re-ranking of priorities, greater engagement in activities, personal growth 
(including being more appreciative and feeling emotionally stronger), and more openness relating to 
others [9]. Another qualitative study proposed that distress may act as a catalyst for growth [10].  
However, the extent of PTG among HNC survivors, and which survivors are more likely to experience 
PTG, remains unclear. The two quantitative studies in HNC suggest PTG is higher in individuals who 
are married, do not have alcohol use disorders, have better social functioning and have higher levels 
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of hope and optimism [11,12], but both studies were small (N=50 and 74, respectively). Moreover, 
one reported only unadjusted results [11] and, in the other, all participants had anxiety or depression 
[12].  
Studies in other cancers have suggested PTG may lead to additional positive effects.  Higher PTG has 
been associated with better quality-of-life [13,14], better physical wellbeing and lower distress [15]. 
In addition, it may mediate the impact of stressors, such as comorbidity, on quality-of-life [16].  
We investigated, in HNC survivors: (i) extent of PTG; (ii) associations between socio-economic 
characteristics, social support, and clinical variables and PTG; and (iii) whether PTG and health-
related quality-of-life (HRQoL) are related. Given the limited previous research on PTG in HNC, our 
analysis was intended to be hypothesis-generating rather than hypothesis-testing. 
METHODS 
Participants 
In April 2012, survivors of primary HNC (ICD10 C00-C14, C32) were identified from the population-
based National Cancer Registry Ireland (NCRI). The NCRI records incident cancers among residents of 
the Republic of Ireland; completeness of registration is high (www.ncri.ie). Eligible survivors were 
≥18 years at diagnosis, ≥eight months post-diagnosis, and treated in one or more of 14 hospitals, 
encompassing all major HNC treating centres in the country. The treating consultant of each survivor 
was invited to confirm the individual: was alive and aware they had cancer; had completed 
treatment; was not in the terminal phase; and that there was no medical or other reason why it 
would be inappropriate to contact them. Survivors considered ineligible by the consultant, or whose 
treating clinician did not respond, were excluded.  
Compliance with ethical standards 
The study accorded with the ethical standards of the 1964 Declaration of Helsinki and later 
amendments. The research ethics committee for each participating hospital approved the study, and 
participants provided signed informed consent. 
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Measures 
A postal questionnaire was distributed to survivors considered eligible by consultants (n=991).  Up to 
two reminders were sent at fortnightly intervals. The questionnaire included the Posttraumatic 
Growth Inventory (PTG-I), a reliable and validated 21-question instrument that measures overall PTG 
and growth in five dimensions: relating to others (7 items), new possibilities (5), personal strength 
(4), spiritual change (2) and appreciation of life (3) [17]. For each item respondents were given a 
statement that described a change they could have experienced (e.g. ‘I have developed new 
interests’) and asked to indicate the degree to which they experienced this change as a result of 
their cancer diagnosis and treatment. Responses options were on a 5-point likert scale, ranging from 
‘0’ (‘I did not experience this change’) to ‘5’ (I experienced this change to a very great degree’). Item 
responses were summed to generate an overall PTG score in the range 0-105; a higher score implies 
greater PTG. We computed scores for each domain; the range of possible scores depends on the 
number of items in the domain. For respondents who answered at least half, but not all, PTG 
questions we imputed missing values using the mean of their responses to the completed questions.  
This was done for the overall score and domain scores. 
The questionnaire collected information on socio-demographic variables (sex, age, marital status, 
highest level of education completed, and number of children).  The deprivation category of the 
survivor’s area of residence (based on 2002 census data [18]) was obtained from the NCRI. Following 
previous work [19], financial circumstances were assessed in terms of: pre-diagnosis financial stress 
(household ability to make ends meet at diagnosis; classified for analysis as difficult vs easy), post-
diagnosis cancer-related financial stress (impact of cancer on household ability to make ends meet; 
classified as more difficult vs no change/less difficult) and post-diagnosis cancer-related financial 
strain (feelings about household’s financial situation since diagnosis with cancer; classified as more 
concerned vs no change/less concerned). Amount of social support was assessed using the Oslo 
Social Support Scale [20], and classified as poor, moderate and strong. Following Gray et al [21], 
survivors rated their agreement with two statements about satisfaction with social support during 
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and after treatment. Regarding clinical variables, the questionnaire asked about recurrence and the 
NCRI database provided information on cancer site, time since diagnosis, and cancer-directed 
treatment(s) received within 8 months of diagnosis. HRQoL was measured using the Functional 
Assessment of Cancer Therapy General questionnaire (FACT-G) and the HNC component (FACT-
H&N), both of which are validated and widely used [22,23]. For each of 39 HRQoL statements, 
participants rated the extent to which they applied in the past 7 days. The total HRQoL score was 
computed as recommended; for respondents who had answered at least half, but not all, 39 
questions missing responses were imputed using the individual’s mean score from completed 
questions. A higher total score indicates higher HRQoL. 
Statistical analysis 
Analysis was conducted in SPSS v23.  Respondents’ and non-respondents’ socio-demographic and 
clinical characteristics were compared using chi-square tests. Primary analysis used the dataset 
including the imputed PTG values. We computed mean overall PTG score, mean domain scores, and 
mean per-question scores. Following Jansen et al [11], a mean overall PTG per-question score <2.5 
was classified as no-little PTG and ≥2.5 was classified as moderate-high PTG. In sensitivity analysis 
we compared scores in the primary dataset with those obtained restricting analysis to respondents 
who answered all PTG questions. Total PTG scores were compared between subgroups defined by 
the socio-economic, social support and clinical variables, using ANOVA tests. A multivariable linear 
regression model was developed. Candidate variables are shown in Table 1. Variables were fitted 
simultaneously if the p-value for the F-test in the relevant univariable regression was <0.2 (because 
of the hypothesis-generating nature of the analysis). Each variable was then dropped individually 
from the model; those where the F-change test p-value was <0.2 were included in the final model. 
Care was taken to avoid multicollinearity; variance inflation factors for the variables in the final 
model were <2.4 and tolerance >0.4.  Assumptions underlying linear regression were not violated. 
To explore the relationship between total PTG and HRQoL we ran a correlation, using Spearman rank 
because HRQoL scores were skewed. For further illumination, we compared the HRQoL score 
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distribution in those with none-little vs moderate-high PTG using the Mann-Whitney U test.  Because 
the cut-off for no-little vs moderate-high PTG is unvalidated,  as a sensitivity analysis we repeated 
this analysis classifying total PTG scores into tertiles (low <49/intermediate 49-70/high >70) so that 
approximately one-third of participants were in each category. 
RESULTS 
Characteristics 
583 survivors participated (response rate=59%).  Respondents and non-respondents did not differ 
significantly by sex, stage or cancer site but respondents were more often <60 (p<0.01) and less 
often 10+ years post-diagnosis (p=0.02).  
Of respondents, 67% were male; ages ranged from 28 to 92; 71% were married/cohabiting; and 36% 
had competed primary level education only (Table 1). The most common site was oral cavity (39%), 
followed by larynx (31%) and oropharynx (16%); 15% had cancer in another site in the head and 
neck. One third had had surgery alone, 39% had surgery with (neo-)adjuvant radiation +/- 
chemotherapy, 17% had radiotherapy alone and 11% chemo-radiation. 
Overall PTG and domain scores 
The mean overall PTG score was 55.7 (95%CI 51.2-58.3); 60% of survivors had a score consistent with 
moderate-high PTG (Table 2). The highest mean scores per question were for appreciation of life 
(3.29) and relating to others (2.98). 
In sensitivity analysis, among respondents who answered all PTG questions (n=387), the mean scores 
were virtually identical to those from the primary analysis dataset (Supplementary table 1). 
Associations between explanatory variables and overall PTG score 
Overall PTG score varied significantly by sex (more growth in females), age at survey (more growth in 
younger survivors), amount of social support (more growth in those with more social support), pre-
diagnosis financial stress (more growth in those with more difficult financial situation) and both 
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cancer-related financial stress and financial strain (more growth in those with more 
difficulties/concerns)(Table 1). 
In the multivariable model, four variables remained associated with overall PTG: sex, age at survey, 
social support and cancer-related financial stress (Table 3). The association with age was borderline 
statistically significant (p=0.07); p<0.05 for the other three variables. Together, these variables 
explained 13.4% of variance. On average, the mean PTG score was 7.21 (95%CI 2.64-11.78) points 
higher in females than males. Compared to respondents <60, the score was slightly (and non-
significantly) lower those aged 60-69 and 7.90 (95%CI 2.27-13.53) points lower in those aged 70+.  
Compared to those with poor social support, the score was 16.32 (95%CI 9.81-22.83) points higher in 
those with moderate support and 21.40 (95%CI 14.95-27.85) points higher in those with strong 
support.  Those who did not experience cancer-related financial stress had a 8.36 (95%CI 3.97-12.75) 
point lower score than those who experienced this.   
Overall PTG and HRQoL 
There was a statistically significant, but weak, correlation between overall PTG and HRQoL 
(Spearman rho=0.12, p<0.01). HRQoL was significantly lower in those with no-little PTG (median 
HRQoL=116.3) than those with moderate-high PTG (median HRQoL=124.1; p=0.01). In the sensitivity 
analysis, classifying PTG into tertiles, this association persisted (low PTG, median HRQoL=116.7; 
intermediate PTG, 120.3; high PTG, 126.0; p=0.01). 
DISCUSSION 
We have documented the extent of PTG in HNC survivors, identified subgroups who experience 
more PTG and demonstrated, for the first time in HNC, a positive association between PTG and 
HRQoL. The mean PTG-I score was 55.74 and 60% scored in the range for moderate-high PTG. While 
this demonstrates HNC survivors may experience PTG, most studies in survivors of other cancers 
which used the same instrument reported higher average scores (see, for example, two breast 
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cancer studies in which the mean PTG scores were 64.1 and 70.2, and a study of those who had had 
bone marrow transplantation following cancer, in which the mean score was 64.7 [24-26]).  The 
mean score here was similar to that reported in one previous HNC study (51.8)[11], but was higher 
than in the other HNC study (30.8); however, in that study, all participants had anxiety or depression 
[12]. It is possible that the impacts of HNC and its treatment (such as the functional limitations and 
problems with activities of daily living) make reassessment of one’s life and adaptation to the 
traumatic event difficult thereby inhibiting PTG.  In addition, HNC incidence is associated with lower 
socio-economic status [27] and other cancer studies have shown associations between lower socio-
economic status (or markers of this) and less PTG [11,14,26]. Cultural differences in PTG have been 
hypothesized [28]. Such differences might possibly explain the low average PTG score in our study, 
but we are not aware of any empirical data to support this.  
Females had more PTG than males, although this was only borderline statistically significant in the 
multivariable model. Most previous cancer studies have found no association between PTG and sex, 
but the few that have documented associations reported greater growth in females [6, and 
references therein], consistent with other traumatic events [29]. Women are more likely to use 
emotion-focussed coping styles, such as positive reappraisal, rumination and positive self-talk [30]. 
Emotion-focussed coping involves thinking about the event and trying to make sense of it [29], 
essentially the process proposed to operate in PTG. There is also some evidence that women tend to 
appraise stressors as more severe than men [30]; potentially, appraising stressors as more severe 
could affect how the individual struggles to make sense of the new reality following the traumatic 
event thereby influencing PTG. However, convincing evidence for gender-differences in coping 
strategies or stressor appraisal in HNC (and links between the latter and PTG) is lacking. Further 
research would be valuable to elucidate these issues.  
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Our finding of more growth in younger survivors is consistent with other cancers [6].  In breast 
cancer it has been suggested that perceiving cancer as more threatening facilitates PTG [31]. While 
information on perceived threat of HNC by age is lacking, younger survivors more often report fear 
of recurrence as their greatest concern [32]. Bellizzi [33] suggested that younger survivors of 
traumatic events experience more growth because they realise they have more time left to 
accomplish desired goals, whereas older survivors reach a peaceful acceptance about their life 
situation. It might be speculated, therefore, that older HNC survivors are more fatalistic or resigned 
to their situation, making them less likely to engage in the emotional processing that can lead to 
PTG. A further possibility is that age may be a marker for another correlate of PTG, such as 
employment status or (absence of) comorbidities [26].   
Survivors who reported more social support also reported greater PTG and the effect was large. 
While this is consistent with Tedeschi and Calhoun’s [6] theoretical model and studies in other 
cancers [34,35], it is important given the high levels of loneliness among HNC survivors [36]. It is 
theorized that having strong social support enables the individual to discuss their feelings, ask for 
advice and make sense of what is happening, ultimately helping them redefine their life’s 
assumptions positively (i.e. generating PTG) [6]. 
The association between cancer-related financial stress and greater PTG is intriguing and, as far as 
we are aware, novel among cancer survivors. In informal caregivers of the survivors in the current 
study we found a similar association [37]. As suggested in that paper, experiencing financial stress 
due to cancer may increase the resulting trauma, enabling more PTG, but this is simply speculation. 
Further exploration of the role of financial and economic factors in PTG is warranted. 
It would be of considerable value to identify potentially modifiable predictors of HRQoL.  Our 
observation that higher PTG is significantly associated, albeit in an unadjusted exploratory analysis in 
a cross-sectional study, with higher HRQoL is consistent with emerging findings for other cancers. 
For example, among 483 colorectal cancer survivors, mean QoL scores were significantly higher in 
  
This article is protected by copyright. All rights reserved. 
those with moderate-high than no-little PTG [13]; among 122 stomach cancer survivors, higher PTG 
was significantly associated with better social/family and functional wellbeing [14]; and in 60 breast 
cancer survivors greater PTG was associated with decreased psychological distress [15]. Thus, it 
appears that PTG may be related to various aspects of HRQoL. Moreover, while experiencing little or 
no PTG may not be detrimental per se, these associations suggest that there may be wider benefits 
to PTG and, moreover, that interventions or strategies to support or enhance PTG might have 
positive impacts on survivors’ HRQoL.   
Clinical implications  
Our findings may make health professionals more alert to the fact that PTG is possible in HNC 
survivors and could be encouraged and supported.  This needs to be done with care as making 
survivors feel like PTG is expected can result in negativity [24]. Interventions to facilitate PTG have 
been developed, but few have been tested in cancer survivors [38], and it is unclear whether or how 
interventions need to be modified for different groups. Indirect routes to encourage PTG may bring 
benefits, such as finding ways to increase social support (e.g. through cancer buddy schemes [39]), or 
adaption of existing interventions to reduce social isolation [40]. Since men and older survivors are 
vulnerable to low PTG, it is important to ensure that any such interventions appeal to these groups.   
From a research perspective, while theories have been postulated as to why some individuals 
experience more PTG than others, empirical data is limited. Qualitative research would be of value 
to explore the pathways which lead to PTG in both male and female HNC survivors, as would 
longitudinal quantitative studies tracking the natural history of PTG over time in different survivor 
groups.  
 
 
 
  
This article is protected by copyright. All rights reserved. 
Study limitations 
This is the largest quantitative study of PTG in HNC. While survivors were identified from a 
population-based sampling frame, the response rate was 59%. Older survivors were less likely to 
participate and respondents who did not complete sufficient PTG questions to be included in 
analysis were more often older and female. Both gender and age were associated with growth but in 
opposite directions making it impossible to be certain whether we may have under- or over-
estimated PTG. In addition, we cannot exclude the possibility that survivors with particularly high, or 
particularly low, PTG participated.  
Conclusions 
Moderate-high PTG is evident in more than half of HNC survivors and some subgroups (women, 
younger survivors, those with social support and those who experience cancer-related financial 
stress) have greater growth. Moreover, greater growth is associated with higher HRQoL, suggesting 
strategies to encourage and support PTG in HNC survivors may yield benefits. 
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Table 1: Respondents’ characteristics, mean overall PTG scores with standard deviations and p 
values  
Variable n %  
Mean 
PTG 
SD  F p-value 
Sex 
 
Male 392 67  51.39 24.73  10.53 <0.01 
 
Female 191 33  60.14 24.20   
 Marital status 
 
Married/cohabiting 413 71  54.14 24.75  0.15 0.70 
 
Other 165 29  54.16 25.30   
 
Children         
 
None 135 24  52.00 25.48  0.72 0.50 
 
1-3 248 45  55.73 24.02   
 
 
4+ 171 31  53.28 25.77   
 
Education         
 
Primary 190 36  54.41 26.43  0.56 0.64 
 
Secondary 254 47  53.82 23.50   
 
 
University 59 11  52.36 27.03   
 
 
Post-graduate 32 6  60.35 20.20   
 
Age at survey         
 
<60 204 35  59.48 22.42  5.47 <0.01 
 
60-69 217 37  58.22 26.44   
 
 
70+ 160 28  50.28 27.46   
 
Deprivation category       
 
1 least deprived 100 23  51.08 24.05  1.02 0.41 
 
2 73 18  54.17 24.27   
 
 
3 81 19  57.02 24.74   
 
 
4 98 18  53.71 26.41   
 
 
5 most deprived 179 33  56.24 24.64   
 
 
Unknown 52 9  49.43 25.51   
 
Cancer site1         
 
Oropharynx 93 16  60.22 22.77  1.73 0.16 
 
Oral cavity 225 39  53.06 24.77   
 
 
Larynx 178 31  53.41 25.96   
 
 
Other 87 15  50.75 24.76   
 
Stage at diagnosis         
 
I 169 41  52.81 25.33  0.45 0.77 
 
II 108 18  55.23 25.40   
 
 
III 77 11  50.95 24.00   
 
 
IV 137 20  58.72 23.43   
 
 
Unstaged 92 15  51.07 26.00   
 
Years since diagnosis         
 
<5  289 50  54.82 24.30  1.43 0.24 
 
5-9 199 34  58.07 25.18   
 
 
10+ 92 16  59.51 29.75   
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Table 1: Cont’d 
Recurrence 
 
Yes 34 6  56.99 22.82  0.31 0.58 
 
No 516 94  53.94 25.02   
 
Treatment received2         
 Radiotherapy alone 86 17  54.54 25.33  1.45 0.23 
 Chemo-radiation 59 11  57.60 22.79    
 Surgery alone 164 33  53.65 26.70    
 Surgery & chemo/radiation  209 39  56.35 25.25    
Amount of social support         
 
Poor 80 14  40.73 26.84  16.45 <0.01 
 
Moderate 223 39  55.09 23.24   
 
 
Strong 262 46  57.75 24.28   
 
Satisfied with social support during treatment       
 
Agree 564 98  54.25 24.64  0.86 0.38 
 
Disagree 9 2  48.75 36.25   
 
Satisfied with social support post-treatment       
 
Agree 555 98  54.32 24.61  2.25 0.13 
 
Disagree 14 2  47.56 33.69   
 
Pre-diagnosis financial situation         
 
Difficult 174 32  58.98 22.81  4.66 0.03 
 
Easy 372 68  54.39 26.51   
 
Cancer-related financial stress         
 
More difficult 272 51  59.89 24.45  13.56 <0.01 
 
No change/less difficult 262 49  51.71 25.86   
 
Cancer-related financial strain         
 
More concerned 286 53  58.88 24.07  7.29 <0.01 
 
No change/less concerned 258 47  52.51 26.56   
 1 oropharynx (C10), oral cavity (C00, C02-C08), larynx (C32), other (C01, base of tongue; C09, tonsil; C11, 
nasopharynx; C12, piriform sinus; C13, hypopharynx) 
2
 within 8 months of diagnosis 
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Table 2: Numbers of subjects1, mean overall, domain-specific and per question PTG scores, with 
95% confidence intervals2 
 
  
n 
Mean 
score 95% CI 
Mean score  
per question 
Overall PTG  539 55.74 53.15 - 58.33 2.70 
     No-little PTG  218 (40.4%)    
     Moderate-high PTG  321 (59.6%)    
Domain 1: Relate to Others  538 20.79 19.95 - 21.63 2.98 
Domain 2: New Possibilities  529 8.70 8.09 - 9.31 1.93 
Domain 3: Personal Strength  537 10.57 10.03 - 11.10 2.90 
Domain 4: Spiritual Change  500 3.90 3.61 - 4.20 2.19 
Domain 5: Appreciation of Life  538 9.13 8.74 - 9.52 3.29 
1 
Survivors who completed all PTGI questions (or all questions in a domain) plus those who completed at least 
half, but not all, questions on the instrument (or relevant subscale) 
2
 Higher score=more PTG 
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Table 3: Variables associated with total PTG in multivariable model 
Variable Unstandardised 
coefficient 
SE t-test p value F-Change p value 
Sex     10.72 <0.01 
 Male Ref      
 Female 7.21 2.33 3.10 <0.01   
Age     2.64 0.07 
 <60 Ref      
 60-69 -0.54 2.51 -0.21 0.83   
 70+ -7.90 2.87 -2.75 <0.01   
Amount of social support     16.41 <0.01 
 Poor Ref      
 Moderate 16.32 3.32 4.91 <0.01   
 Strong 21.40 3.29 6.51 <0.01   
Cancer-related financial stress 5.02 0.03 
 More difficult Ref      
 No change/Less 
difficult 
-8.36 2.24 -3.74 <0.01   
Constant=43.48 
 
